Expression of concern
Article first published online: 11 JUN 2012
DOI: 10.1111/j.1365-2125.2012.04348.x
© 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society
Additional Information
How to Cite
(2012), Expression of concern. British Journal of Clinical Pharmacology, 74: 223. doi: 10.1111/j.1365-2125.2012.04348.x
Publication History
- Issue published online: 11 JUN 2012
- Article first published online: 11 JUN 2012
The contribution of clinical pharmacology to antimalarial drug discovery and development
Vol. 55, Issue 5, 464–468, Article first published online: 20 MAY 2003
- Abstract
- Article
- References
- Cited By
The following article ‘Winstanley, P. The contribution of clinical pharmacology to antimalarial drug discovery and development. British Journal of Clinical Pharmacology 2003; 55: 464–8’ was an invited review based on a lecture, published online on 20 May 2003 on the Wiley Online Library. This article is a similar, but updated, version of an article previously published in The Lancet Infectious Diseases, ‘Winstanley, P. (2001), Modern chemotherapeutic options for malaria. The Lancet Infectious Diseases, 1: 242–50’. The Editor of BJCP is satisfied that, while the reduplication of text from the earlier article was not good practice, there is a difference between the earlier and later work. The author, editor and publisher apologize for this failure to follow normal publication practice.
REFERENCE
- 1The contribution of clinical pharmacology to antimalarial drug discovery and development. Br J Clin Pharmacol 2003; 55: 464–8.

1365-2125/asset/olbannerleft.gif?v=1&s=e86b92cac3efbbd2e255b9fa97ece9623eac0b54)
1365-2125/asset/olbannerright.gif?v=1&s=6a7c47d290382bf3bc40c62461bc36a371a081bf)
